## CHD: Church & Dwight Co., Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%); PEG 1.93 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($81.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Raymond James upgrades Church & Dwight as 2026 to see M&As upside**
- Source: Investing.com Canada | 20260105T151442 | Bullish | Relevance: 100%
- Raymond James upgraded Church & Dwight Company Inc (NYSE:CHD) to Outperform from Market Perform, citing the household and personal care company's strong positioning for 2026 after a share pullback and strategic acquisitions/divestitures. The firm believes the stock's underperformance has created an attractive entry point, and that an improved business mix and modest debt levels provide upside for future growth and M&A. Raymond James set a price target of $100 for CHD.

**2. Arm & Hammer and Trojan parent sets Jan. 30 webcast on 2025 results**
- Source: Stock Titan | 20260105T142652 | Neutral | Relevance: 100%
- Church & Dwight Co., Inc. (NYSE: CHD) will host a webcast from its 2026 Analyst Day to discuss fourth quarter and full-year 2025 earnings results on January 30, 2026, at 12:00 p.m. ET. The event will be accessible live and for replay on the company's investor relations website. Church & Dwight is a leading U.S. producer of sodium bicarbonate and markets a wide range of personal care, household, and specialty products under well-known brand names.

**3. Church & Dwight to Webcast the 2026 Analyst Day and Full Year 2025 Earnings Results on January 30**
- Source: Business Wire | 20260105T140808 | Neutral | Relevance: 100%
- Church & Dwight Co., Inc. (NYSE: CHD) announced it will host a webcast for its 2026 Analyst Day and to discuss fourth quarter and full-year 2025 earnings results on January 30, 2026, at 12:00 p.m. ET. Investors and media can access the live webcast and replay on the company's investor relations website. The company is a leading producer of sodium bicarbonate and markets a wide range of personal care, household, and specialty products under well-known brand names.

**4. Wells Fargo Adjusts Price Target on Church & Dwight Co to $92 From $100, Maintains Overweight Rating**
- Source: marketscreener.com | 20260105T155442 | Somewhat-Bearish | Relevance: 100%
- Wells Fargo has adjusted its price target for Church & Dwight Co. (CHD) to $92, down from the previous $100, while maintaining an "Overweight" rating on the stock. This revision comes amidst various analyst actions on the consumer products company, including both upgrades and price target adjustments from other firms. The article details recent analyst recommendations and company news, such as sales of certain brands and earnings guidance.

**5. Church & Dwight Co., Inc. $CHD Shares Bought by Generali Asset Management SPA SGR**
- Source: MarketBeat | 20260104T110748 | Somewhat-Bullish | Relevance: 100%
- Generali Asset Management SPA SGR significantly increased its stake in Church & Dwight Co., Inc. (NYSE:CHD) during the third quarter of 2025 by 97.1%, now holding 34,811 shares valued at approximately $3.05 million. This move is part of a broader trend of institutional investment, with firms like Norges Bank also establishing new positions, leading to institutional investors owning around 86.6% of the company. Church & Dwight reported strong Q3 earnings, surpassing expectations with $0.81 EPS and $1.59 billion in revenue, and has a consensus "Hold" rating from analysts with an average price target of $99.47.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Wells Fargo | $92 | $100 | -8% |
| 2026-01-05 | Raymond James | $100 | $0 | 0% |
| 2025-12-17 | Citigroup | $87 | $85 | +2% |
| 2025-12-17 | Jefferies | $102 | $97 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Wells Fargo | main | Overweight |
| 2026-01-05 | Raymond James | up | Outperform |
| 2025-12-17 | Citigroup | up | Neutral |
| 2025-12-17 | Jefferies | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 18 ($0.04M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 9.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.93 elevated, pricing in significant growth expectations. Forward P/E 22.5x stretched relative to 7% growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.5B |
| Beta | 0.46 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.93 |
| Forward P/E | 22.5 |
| Current P/E | 24.1 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.4% (minimal 5-day change). Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 48. OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.41% (CS: 33) | Neutral |
| RSI_14 | 48.2 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 0.904x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $84.12
- **Stop Loss:** $81.16 (3.5% risk)
- **Target:** $87.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 194
- **Position Value:** $16,319.28
- **Portfolio %:** 16.32%
- **Risk Dollars:** $575.00
- **Risk Per Trade:** 0.57%
- **Modifiers:** L1 115% | L2 50% | Combined 0.57x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*